Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 77
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06686745 | Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors | ||
| NCT05071703 | Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study | ||
| NCT05148195 | A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors | ||
| NCT04671849 | An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations. | ||
| NCT05731804 | Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir | ||
| NCT02916420 | Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma | ||
| NCT05475834 | Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants | ||
| NCT04440436 | Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients | ||
| NCT01847118 | A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors | ||
| NCT04413227 | A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors | ||
| NCT01909856 | The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy | ||
| NCT05569057 | A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma | ||
| NCT01109264 | Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia | ||
| NCT03763123 | A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer. | ||
| NCT01531790 | A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients | ||
| NCT06654791 | Mass Balance Clinical Trial of SIM0270 | ||
| NCT02004548 | Phase I Clinical Study of Metatinib Tromethamine Tablet | ||
| NCT01772732 | Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC | ||
| NCT01410370 | Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases | ||
| NCT02805010 | Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously | ||
| NCT02088515 | Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma | ||
| NCT05373433 | To Evaluate SSD8432/Ritonavir in Adults With COVID-19 | ||
| NCT04942301 | PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy | ||
| NCT01459081 | Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China | ||
| NCT04714177 | Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage | ||
| NCT01554917 | A Study of Iguratimod in Patients With Active Rheumatoid Arthritis | ||
| NCT06680921 | A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE) | ||
| NCT05781360 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors | ||
| NCT02375022 | Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations | ||
| NCT05254665 | A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors | ||
| NCT04908787 | A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer | ||
| NCT06375044 | Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT02430350 | Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke | ||
| NCT07050459 | A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors | ||
| NCT06326723 | Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects | ||
| NCT04914598 | A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions | ||
| NCT06370416 | the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib | ||
| NCT02722694 | A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate | ||
| NCT05665647 | Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants | ||
| NCT05781386 | A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors | ||
| NCT01929096 | Compound Edaravone Injection for Acute Ischemic Stroke | ||
| NCT05373446 | Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study | ||
| NCT05803135 | Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis | ||
| NCT01327235 | Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites | ||
| NCT02283476 | The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. | ||
| NCT01368419 | Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients | ||
| NCT07007988 | A Phase I Study of SIM0388 in Participants With Malignant Ascites. | ||
| NCT05369676 | To Evaluate SSD8432/ Ritonavir in Adults With COVID-19 | ||
| NCT05293964 | Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer | ||
| NCT06022354 | To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SIM0278 in Chinese Healthy Subjects |
